| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9375498 | AAA USA INC | Process for the preparation of complexes of 68Ga |
Aug, 2032
(8 years from now) | |
Netspot is owned by Aaa Usa Inc.
Netspot contains Gallium Dotatate Ga-68.
Netspot has a total of 1 drug patent out of which 0 drug patents have expired.
Netspot was authorised for market use on 01 June, 2016.
Netspot is available in powder;intravenous dosage forms.
Drug patent challenges can be filed against Netspot from 01 June, 2020.
The generics of Netspot are possible to be released after 10 August, 2032.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-120) | Jun 01, 2023 |
| Orphan Drug Exclusivity(ODE) | Jun 01, 2023 |
| New Chemical Entity Exclusivity(NCE) | Jun 01, 2021 |
Drugs and Companies using GALLIUM DOTATATE GA-68 ingredient
NCE-1 date: 01 June, 2020
Market Authorisation Date: 01 June, 2016
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
NETSPOT family patents
